TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer
THURSDAY, Jan. 16, 2025 (HealthDay News) — For patients with unresectable, nonmetastatic...
Read More
Pharmacy
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
THURSDAY, Jan. 16, 2025 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Semaglutide Doubles Risk for Nonarteritic Anterior Ischemic Optic Neuropathy
TUESDAY, Jan. 14, 2025 (HealthDay News) — Use of once-weekly semaglutide more than doubles...
Read More
Differences Exist in Precision Oncology Drug Eligibility Among Patient Ancestral Groups
TUESDAY, Jan. 14, 2025 (HealthDay News) — Ancestry-based differences in frequencies of...
Read More
2015 to 2022 Saw Rise in Ketamine Use
TUESDAY, Jan. 14, 2025 (HealthDay News) — There have been shifts in both the patterns and...
Read More
Polypill Treatment Offers High Value in Low-Income, Underserved Population
MONDAY, Jan. 13, 2025 (HealthDay News) — Polypill treatment for cardiovascular disease...
Read More
Shorter Treatment Regimens Recommended for Tuberculosis
MONDAY, Jan. 13, 2025 (HealthDay News) — In a clinical practice guideline issued by the...
Read More
Perioperative GLP-1 RA Use Reduces Risk for Complications in Patients With Diabetes
MONDAY, Jan. 13, 2025 (HealthDay News) — For patients with diabetes undergoing a surgical...
Read More
FDA Adds Warning Label to RSV Vaccines Abrysvo and Arexvy
MONDAY, Jan. 13, 2025 (HealthDay News) — The U.S. Food and Drug Administration now requires...
Read More
Oral Glucose-Lowering Agents Potential Alternatives to Insulin for Gestational Diabetes
THURSDAY, Jan. 9, 2025 (HealthDay News) — With respect to the proportion of infants born...
Read More
Talquetamab Plus Teclistamab Shows Promise in Multiple Myeloma
THURSDAY, Jan. 9, 2025 (HealthDay News) — For patients with relapsed or refractory multiple...
Read More
Prenatal Exposure to Glucocorticoids May Increase Risk for Some Mental Disorders in Offspring
THURSDAY, Jan. 9, 2025 (HealthDay News) — Prenatal exposure to glucocorticoids is associated...
Read More
Position Statement Developed for Managing Blood Cancers in Pregnancy
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — In a new position statement published online Jan....
Read More
Eight in 10 Infants Received RSV Protection in the 2023 to 2024 Season
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — Eight in 10 infants received respiratory...
Read More
Gender-Affirming Medication Use Rare in U.S. Transgender Adolescents From 2018 to 2022
MONDAY, Jan. 6, 2025 (HealthDay News) — Among privately insured U.S. adolescents who...
Read More
Incident Gabapentin Use Not Linked to Increase in Falls Versus Duloxetine
TUESDAY, Jan. 7, 2025 (HealthDay News) — Incident use of gabapentin is not associated with...
Read More
DoxyPEP Tied to Decreases in Sexually Transmitted Infections
TUESDAY, Jan. 7, 2025 (HealthDay News) — Doxycycline postexposure prophylaxis (doxyPEP)...
Read More
Denosumab Increases Cardiovascular Risk in Dialysis-Dependent Patients
TUESDAY, Jan. 7, 2025 (HealthDay News) — For dialysis-dependent patients treated for...
Read More
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
TUESDAY, Jan. 7, 2025 (HealthDay News) — For adults with overweight or obesity without...
Read More
Immunocompromised Have Heterogeneous Antibody Response to RSV Vaccines
TUESDAY, Jan. 7, 2025 (HealthDay News) — For immunocompromised individuals, antibody...
Read More